The state is taking action against three major drug companies and the big pharmacy benefit managers in an effort to temper costs for people with diabetes.
A new study finds a steady drop since 1945 in disruptive feats as a share of the world’s booming enterprise in scientific and technological advancement.
As a new chatbot wows the world with its conversational talents, a resurgent tech giant is poised to reap the benefits while doubling down on a relationship with the start-up OpenAI.